AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Dickman, R Alava, M Munoz, MA Peltola, J Vespignani, A Zapperi, S
Citation: R. Dickman et al., Critical behavior of a one-dimensional fixed-energy stochastic sandpile - art. no. 056104, PHYS REV E, 6405(5), 2001, pp. 6104

Authors: Eriksson, K Peltola, J Keranen, T Haapala, AM Koivikko, M
Citation: K. Eriksson et al., High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases, EPILEPSY R, 46(2), 2001, pp. 129-137

Authors: Peltola, J Keranen, T Rainesalo, S Hurme, M
Citation: J. Peltola et al., Polymorphism of the interleukin-1 gene complex in localization-related epilepsy, ANN NEUROL, 50(2), 2001, pp. 275-276

Authors: Hietaharju, A Peltola, J Seppa, J Luukkainen, R Dastidar, P
Citation: A. Hietaharju et al., The coexistence of systemic lupus erythematosus and multiple sclerosis in a mother and daughter, SC J RHEUM, 30(2), 2001, pp. 120-122

Authors: Sillanpaa, J Peltola, J Nordlund, K Keinonen, J Puska, MJ
Citation: J. Sillanpaa et al., Electronic stopping calculated using explicit phase shift factors - art. no. 134113, PHYS REV B, 6313(13), 2001, pp. 4113

Authors: Peltola, J Andersson, MA Haahtela, T Mussalo-Rauhamaa, H Rainey, FA Kroppenstedt, RM Samson, RA Salkinoja-Salonen, MS
Citation: J. Peltola et al., Toxic-metabolite-producing bacteria and fungus in an indoor environment, APPL ENVIR, 67(7), 2001, pp. 3269-3274

Authors: Peltola, J Ukkonen, M Moilanen, E Elovaara, I
Citation: J. Peltola et al., Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy, NEUROLOGY, 57(5), 2001, pp. 895-896

Authors: Ainiala, H Loukkola, J Peltola, J Korpela, M Hietaharju, A
Citation: H. Ainiala et al., The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus, NEUROLOGY, 57(3), 2001, pp. 496-500

Authors: Palmio, J Peltola, J Vuorinen, P Laine, S Suhonen, J Keranen, T
Citation: J. Palmio et al., Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures, J NEUR SCI, 183(1), 2001, pp. 27-31

Authors: Nordlund, K Peltola, J Nord, J Keinonen, J Averback, RS
Citation: K. Nordlund et al., Defect clustering during ion irradiation of GaAs: Insight from molecular dynamics simulations, J APPL PHYS, 90(4), 2001, pp. 1710-1717

Authors: Peltola, J Krapp, KC
Citation: J. Peltola et Kc. Krapp, Recursive preferences in forest management, FOREST SCI, 47(4), 2001, pp. 455-465

Authors: Ainiala, H Hietaharju, A Loukkola, J Peltola, J Korpela, M Metsanoja, R Auvinen, A
Citation: H. Ainiala et al., Validity of the new American college of rheumatology criteria for neuropsychiatric lupus syndromes: A population-based evaluation, ARTH RH ART, 45(5), 2001, pp. 419-423

Authors: Peltola, J Erikson, K Keranen, T
Citation: J. Peltola et al., Cytokines and seizures, ARCH NEUROL, 58(7), 2001, pp. 1168-1168

Authors: Moller, EM Peltola, J
Citation: Em. Moller et J. Peltola, Isolation of high-molecular-weight DNA from mycelium and the recalcitrant and heavily pigmented spores of Stachybotrys chartarum, ANALYT BIOC, 297(1), 2001, pp. 99-101

Authors: Peltola, J Palmio, J Korhonen, L Suhonen, J Miettinen, A Hurme, M Lindholm, D Keranen, T
Citation: J. Peltola et al., Interleukin-6 and Interleukin-1 receptor antagonist in cerebrospinal fluidfrom patients with recent tonic-clonic seizures, EPILEPSY R, 41(3), 2000, pp. 205-211

Authors: Kuusilehto, A Happonen, RP Peltola, J Lehtinen, R Jansen, CT
Citation: A. Kuusilehto et al., The effect of PUVA on Langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen, PHOTODERM P, 16(3), 2000, pp. 129-133

Authors: Peltola, J Kulmala, P Isojarvi, J Saiz, A Latvala, K Palmio, J Savola, K Knip, M Keranen, T Graus, F
Citation: J. Peltola et al., Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy, NEUROLOGY, 55(1), 2000, pp. 46-50

Authors: Murros, K Kataja, M Hedman, C Havanka, H Sako, E Farkkila, M Peltola, J Keranen, T
Citation: K. Murros et al., Modified-release formulation of tizanidine in chronic tension-type headache, HEADACHE, 40(8), 2000, pp. 633-637

Authors: Elovaara, I Ukkonen, M Leppakynnas, M Lehtimaki, T Luomala, M Peltola, J Dastidar, P
Citation: I. Elovaara et al., Adhesion molecules in multiple sclerosis - Relation to subtypes of diseasemethylprednisolone therapy, ARCH NEUROL, 57(4), 2000, pp. 546-551

Authors: Dastidar, P Heinonen, T Lehtimaki, T Ukkonen, M Peltola, J Erila, T Laasonen, E Elovaara, I
Citation: P. Dastidar et al., Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis, J NEUR SCI, 165(1), 1999, pp. 36-42

Authors: Andersson, MA Mikkola, R Kroppenstedt, RM Rainey, FA Peltola, J Helin, J Sivonen, K Salkinoja-Salonen, MS
Citation: Ma. Andersson et al., The mitochondrial toxin produced by Streptomyces griseus strains isolated from an indoor environment is valinomycin, APPL ENVIR, 64(12), 1998, pp. 4767-4773

Authors: Peltola, J Hietaharju, A Rantala, I Lehtinen, T Haapasalo, H
Citation: J. Peltola et al., A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease, ACT NEUR SC, 98(5), 1998, pp. 360-363
Risultati: 1-22 |